NCT01798667View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation

PHASE2UnknownINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

September 30, 2013

Conditions
Premature Ejaculation
Interventions
DRUG

DA-8031

DRUG

Placebo

Placebo of DA-8031, undistinguishable

Trial Locations (1)

Unknown

RECRUITING

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY